Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital

• click to rate

  Posted by Two Blokes Wed at 2:00 PM - Filed in Stock - 2 views
  
  Bluebird bio and Carlyle Group and SK Capital Partners said on Wednesday that the private equity firms have offered $5 per share upfront to takeover the gene therapy maker.